IL13 and neoplasm: Eosinophils and mast cells might inhibit Th1 anti-tumor immunity by releasing Th2 cytokines such as IL-4 and IL-13, but their metabolic pathways (such as cytochrome P450) that were highly expressed at the same time might play a protective role by clearing carcinogens (52, 53).